Synthego: EditCo Bio and Telegraph Hill Partners' Acquisition of Synthego's Engineered Cell Solutions Business
Fenwick & West represented Synthego in the transaction. EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions [...]
Read full article »
Synthego is a California-based genome engineering company that develops a platform offering CRISPR-based gene therapies and diagnostic tests for the healthcare industry.
Read more